Search

everythinglearnresearchcommunity

for

Search:↓

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

A 10-year-old girl with Fox Fordyce disease improved with treatment, suggesting the disease can occur before puberty and might be underdiagnosed in young girls.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Nanoemulgel is a promising method for delivering drugs, especially for those that don't dissolve well in water.

Spaceflight can harm skin health by altering gene expression, affecting DNA, mitochondria, and skin barriers.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

Low-level laser therapy did not reduce licking or improve lesions in dogs with ALD but did increase hair growth.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

Google Search ads effectively gathered a diverse dermatology image dataset for research and AI development.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Gray hair can potentially be reversed, leading to new treatments.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.

New cytokine-targeted therapies show promise for treating alopecia areata.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

Immune cells are crucial for normal skin development and their dysfunction can cause skin disorders.

Tofacitinib is effective and safe for treating severe alopecia areata.

Menopause-related skin changes may increase fungal infections and inflammation.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Cell death shapes skin stem cell environments, affecting inflammation, repair, and cancer.

A standardized consent form for PRP injections improves patient trust and legal protection.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.